350 Prolonged Somnolence and Recovery, Sneezing, Coughing, Mg)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Clinical Evaluation of Pipecuronium Bromide and Its Comparison With
Scholars Journal of Applied Medical Sciences (SJAMS) ISSN 2320-6691 (Online) Sch. J. App. Med. Sci., 2013; 1(6):943-950 ISSN 2347-954X (Print) ©Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources) www.saspublisher.com Research Article Clinical Evaluation of Pipecuronium Bromide and its Comparison with Pancuronium Bromide Kaushal RP Associate Professor, Department of cardiac anesthesia, Gandhi Medical College, Bhopal, India. *Corresponding author Kaushal RP Email: Abstract: The study was carried out to compare the intubating conditions, cardiovascular responses, neuro-muscular blocking properties and reversal characteristics of pipecuronium bromide and pancuronium bromide. This is a prospective hospital based study. 100 patients belonging to ASA grade I or II physical status aged 18 to 70 years were divided into two groups of 50 patients each. Group 1 received pipecuronium bromide in the dose of .08 mg / kg and group 2 patients received pancuronium bromide in dose of 0.1 mg/kg. Each patient was pre medicated uniformly. Time for onset of apnoea for pipecuronium and pancuronium were 91.64+ 3.59 sec. and 118.84 + 12.53 sec. respectively. The mean time for intubation was 126.60 +12.55 sec. and 144.60 + 22.87 sec. with pipecuronium and pancuronium respectively. Mean duration of block for pipecuronium was 78.64 + 8.97 min. the block for pancuronium lasted from +36-40 min with a mean duration of block 41.60+ 5.57 min. The mean duration of maintenance dose in pipecuronium cases was 45.08 + 7.19 min., while it was 27.06 + 5.01 min in pancuronium cases. -
LETHAL INJECTION: the Medical Technology of Execution
LETHAL INJECTION: The medical technology of execution Introduction From hanging to electric chair to lethal injection: how much prettier can you make it? Yet the prettier it becomes, the uglier it is.1 In 1997, China became the first country outside the USA to carry out a judicial execution by lethal injection. Three other countriesGuatemala, Philippines and Taiwancurrently provide for execution by lethal injection but have not yet executed anyone by that method2. The introduction of lethal injection in the USA in 1977 provoked a debate in the medical profession and strong opposition to a medical role in such executions. To 30 September 1997, 268 individuals have been executed by lethal injection in the USA since the first such execution in December 1982 (see appendix 2). Reports of lethal injection executions in China, where the method was introduced in 1997, are sketchy but early indications are that there is a potential for massive use of this form of execution. In 1996, Amnesty International recorded more than 4,300 executions by shooting in China. At least 24 lethal injection executions were reported in the Chinese press in 1997 and this can be presumed to be a minimum (and growing) figure since executions are not automatically reported in the Chinese media. Lethal injection executions depend on medical drugs and procedures and the potential of this kind of execution to involve medical professionals in unethical behaviour, including direct involvement in killing, is clear. Because of this, there has been a long-standing campaign by some individual health professionals and some professional bodies to prohibit medical participation in lethal injection executions. -
Pancuronium Bromide (Pavulon | Evaluation of Its Clinical Pharmacology*
PANCURONIUM BROMIDE (PAVULON | EVALUATION OF ITS CLINICAL PHARMACOLOGY* ALLEN B. DOBKIN, M.D., WILLIAM EVEBS,M.D., SION GHANOONI, M.D., ASHLEYA. LEVY, VH.D., AND EDWARDT. THOMAS,M.B. PANCURONIUMBROMIDE IS AN amino steroid muscle relaxant (Figure 1) which was synthesized in 1964 by Hewett and Savage and has been studied and evaluated clinically in Europe during the past four years2-5 It is an odourless, white, crystal- line powder with a bitter astringent taste, melts at 215~ with decomposition, and is soluble in 50 parts of chloroform and one part water at 20~ The co]ourless solution is stable while sealed, but breaks down in a few hours after exposure to air. In Europe it is available in 2-ml ampoules containing 4 mg pancuronium bro- mide, 18 nag sodium chloride B.P. and water for injection B.P. to 2 mls. The prepara- tion which was used in this study contains preservatives (acetic acid and sodium acetate) to buffer the solution to pH 4.0. OOC.CH 3N~~ 2BP- CH3CO0 H H20 -- Pancur'ontum Bromide - Pavuton (R) FIGURE 1. Structural formula for paneuronium bromide - Pavulon| Pharmacological studies have shown that it has no hormonal action but is a potent non-depolarizing skeletal muscle relaxant like'tubocurarine and gallamine. It has a more rapid onset of action than tubocurarine with a similar duration of action. It has a somewhat longer action than gallamine. It has no significant effect on the blood pressure or the tracheobronchial tree due to the very. slight ganglion- blocking action and the claim is that no histamine is released, a It does not affect *From the Department of Anesthesiology, State University Itospital, State University of New York, Upstate Medical Center, Syracuse, New York, 13210, U.S.A. -
Administrative Segregation & Death Row Plan-1
Texas Department of Criminal Justice ------------------- Brad Livingston Executive Director () ?1)13 August 14,2013 VIA REGULAR MAIL Todd Hettenbach I WilmerHale 1875 Pennsylvania Avenue NW Washington, DC 20006 RE: Texas Civil Rights Project Dear Mr. Hettenback: In response to your open records request dated August 2, 2013 we have the "Death Row Plan (October 2004)" and "Administrative Segregation Plan (March 2012)", responsive to your request. If have any questions, please do not hesitate to contact this office. rY· .. !f};;JJ= tattenburg, A ministrator · Plans and Operations Texas Department of Criminal Justice Con-ectional Institutions Division /klj P.O. Box99 Huntsville, Texas 77342-0099 www.tdcj.state.tx.us TEXAS DEPARTMENT OF CRIMINAL JUSTICE Administrative Segregation Plan FOREWORD There are occasions within a conectional setting when it becomes necessary to administratively segregate offenders in order to preserve the safety and security of both offenders and staff. The Texas Department of Criminal Justice (TDCJ) policy, Administrative Directive (AD)-03.50, "Administrative Segregation" directs the TDCJ to develop an Administrative Segregation Plan which establishes uniform mles and regulations to guide staff in both the conditions and procedures relating to offenders housed in administrative segregation. The TDCJ is fully committed to abide by and enforce the provisions outlined herein, and all employees are expected to comply with its requirements. ACA References: 4-4140,4-4235,4-4250,4-4251-1,4-4253,4-254,4-4257,4-4258,4-4260,4-4261,4- 4262, 4-4263, 4-4265, 4-4266, 4-4268, 4-4269, 4-4270, and 4-4273 Supersedes: Administrative Segregation Plan, August 2005 3-o6 ·!20/1. -
Opinion 06-70026
United States Court of Appeals Fifth Circuit FILED REVISED JUNE 26, 2006 June 20, 2006 IN THE UNITED STATES COURT OF APPEALS Charles R. Fulbruge III FOR THE FIFTH CIRCUIT Clerk No. 06-70026 LAMONT REESE, Plaintiff-Appellant, versus BRAD LIVINGSTON; NATHANIEL QUARTERMAN, Director, Texas Department of Criminal Justice, Correctional Institutions Division; CHARLES O’REILLY, Senior Warden, Huntsville Unit, Huntsville, Texas; UNKNOWN EXECUTIONERS, Defendants-Appellees. Appeal from the United States District Court For the Northern District of Texas Before HIGGINBOTHAM, DAVIS, and PRADO, Circuit Judges. PATRICK E. HIGGINBOTHAM, Circuit Judge: Proceeding under 42 U.S.C. § 1983, Lamont Reese seeks a stay of his execution scheduled for June 20, 2006. He attacks the method of execution by injection as administered in Texas as cruel and unusual punishment under the Eighth Amendment. The suit does not challenge the conviction or sentence of death. I On December 8, 2000, following his conviction for capital murder in the 371st Judicial District Court of Tarrant County, Texas, Reese was sentenced to death. The Texas Court of Criminal Appeals affirmed his judgment and sentence. Reese v. State, No. 23,989 (Tex. Crim. App. Nov. 6, 2002), cert. denied, Reese v. State, 123 S. Ct. 2581 (2003). Reese filed a state petition for habeas corpus on July 16, 2002, and a supplemental application on January 31, 2003. The Texas Court of Criminal Appeals denied the petition. Ex Parte Reese, Nos. 55,443-01 and 55,443-02 (Tex. Crim. App. Apr. 30, 2003). Turning to the federal courts, Reese’s application for COA was denied by this Court on May 4, 2004. -
Use of Chemical Chelators As Reversal Agents for Drug
(19) TZZ_ _ZZZ_T (11) EP 1 210 090 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/724 (2006.01) A61K 31/194 (2006.01) 18.06.2014 Bulletin 2014/25 A61P 39/04 (2006.01) (21) Application number: 00964006.1 (86) International application number: PCT/EP2000/007694 (22) Date of filing: 07.08.2000 (87) International publication number: WO 2001/012202 (22.02.2001 Gazette 2001/08) (54) USE OF CHEMICAL CHELATORS AS REVERSAL AGENTS FOR DRUG- INDUCED NEUROMUSCULAR BLOCK VERWENDUNG VON CHEMISCHEN CHELATOREN ZUR UMKEHRUNG VON PHARMAKOLOGISCH-INDUZIERTER NEUROMUSKULÄRER BLOCKIERUNG UTILISATION D’AGENTS CHIMIQUES CHELATANTS COMME AGENTS DE NEUTRALISATION DU BLOCAGE NEUROMUSCULAIRE PROVOQUE PAR DES MEDICAMENTS (84) Designated Contracting States: (56) References cited: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU AU-A- 3 662 895 MC NL PT SE • B DESIRE: "Inactivaton of sarin and soman by (30) Priority: 13.08.1999 EP 99306411 cyclodextrins in vitro" EXPERIENTIA, vol. 43, no. 4, 1987, pages 395-397, XP000907287 (43) Date of publication of application: • B. DESIRE: "Interaction of soman with beta- 05.06.2002 Bulletin 2002/23 cyclodextrin" FUNDAMENTAL AND APPLIED TOXICOLOGY, vol. 7, no. 4, 1986, pages 647-657, (73) Proprietor: Merck Sharp & Dohme B.V. XP000911170 2031 BN Haarlem (NL) • C. MAY: "Development of a toxin-binding agent as a treatment for tunicamycinuracil toxicity: (72) Inventors: protection against tunicamycin poisoning of • BOM, Antonius, Helena, Adolf sheep" AUSTRALIAN VETERINARY JOURNAL, Ratho, Midlothian EH28 8NY (GB) vol. 76, no. -
Florida Bishops Want End to Death Penalty, Halt of July 1 Execution
Florida bishops want end to death penalty, halt of July 1 execution ORLANDO, Fla. – Florida’s Catholic bishops have called on Gov. Charlie Christ to “set a new standard of respect for life” in the state by ending the use of the death penalty, beginning by halting the July 1 scheduled execution of Mark Dean Schwab. Schwab, 39, is on death row for the April 18, 1991, rape and murder of 11-year-old Junny Rios-Martinez of Cocoa. In a letter to Christ dated June 25, the bishops said they are praying for the victim and know they are unable to fully grasp the pain experienced by his family. They lamented, though, that taking the life of another who has killed perpetuates violence as a solution. “The Lord commands us to forgive, just as our heavenly Father has forgiven us. It is only through the process of forgiveness that we are healed and our suffering can be alleviated,” said Bishop Victor B. Galeone of St. Augustine. The bishop’s statement was in a press release issued by the Florida Catholic Conference in Tallahassee. He is the episcopal moderator for the State Pro-Life Coordinating Committee of the conference, the public policy arm of the state’s bishops. Schwab was scheduled to die by lethal injection Nov. 15, 2007, but the execution was blocked a day earlier by the U.S. Supreme Court while the court considered a Kentucky case on the constitutionality of lethal injection as a method of execution. Schwab’s was the first execution to be scheduled in Florida since the high court’s April 16 ruling this year which said the use of the three-drug cocktail is not cruel and unusual punishment. -
Lethal Injection and the Right of Access: the Intersection of the Eighth and First Amendments
San Jose State University SJSU ScholarWorks Faculty Publications, School of Management School of Management 1-1-2014 Lethal Injection and the Right of Access: The Intersection of the Eighth and First Amendments Timothy F. Brown [email protected] Follow this and additional works at: https://scholarworks.sjsu.edu/org_mgmt_pub Part of the Constitutional Law Commons, Criminal Law Commons, Criminal Procedure Commons, First Amendment Commons, and the Law Enforcement and Corrections Commons Recommended Citation Timothy F. Brown. "Lethal Injection and the Right of Access: The Intersection of the Eighth and First Amendments" ExpressO (2014). This Unpublished Paper is brought to you for free and open access by the School of Management at SJSU ScholarWorks. It has been accepted for inclusion in Faculty Publications, School of Management by an authorized administrator of SJSU ScholarWorks. For more information, please contact [email protected]. Lethal Injection and the Right of Access: The Intersection of the Eighth and First Amendments By: Timothy F. Brown Introduction The Spring and Summer of 2014 have witnessed renewed debate on the constitutionality of the death penalty after a series of high profile legal battles concerning access to lethal injection protocols and subsequent questionable executions. Due to shortages in the drugs traditionally used for the lethal injection, States have changed their lethal injection protocols to shield information from both the prisoners and the public. Citing public safety concerns, the States refuse to release information concerning the procurement of the drugs to the public. Such obstruction hinders the public’s ability to determine the cruelty of the punishment imposed and creates the potential for unconstitutional execution. -
Expression of Multiple Populations of Nicotinic Acetylcholine
EXPRESSION OF MULTIPLE POPULATIONS OF NICOTINIC ACETYLCHOLINE RECEPTORS IN BOVINE ADRENAL CHROMAFFIN CELLS DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in the Graduate School of The Ohio State University By Bryan W. Wenger, B.A. The Ohio State University 2003 Dissertation Committee: Approved by: Professor Dennis B. McKay, Advisor Professor R. Thomas Boyd ________________________ Advisor Professor Popat N. Patil College of Pharmacy Professor Lane Wallace, Ph.D. ABSTRACT The importance of the role of nAChRs in physiological and pathological states is becoming increasingly clear. It is apparent that there are multitudes of nAChR subtypes with different expression patterns, pharmacologies and functions that may be important in various disease states. Therefore, a greater understanding of nAChR subtypes is essential for potential pharmacological intervention in nAChR systems. Bovine adrenal chromaffin cells are a primary culture of a neuronal type cell that express ganglionic types of nAChRs whose activation can be related to a functional response. While much is known about the outcome of functional activation of adrenal nAChRs, little work has been done in characterizing populations of nAChRs in adrenal chromaffin cells. These studies characterize the pharmacology and regulation of populations of nAChRs found in bovine adrenal chromaffin cells. The primary findings of this research include 1) the characterization of an irreversible antagonist of adrenal nAChRs, 2) the discovery of -
Midazolam Injection, USP
Midazolam Injection, USP 2 mg per 2 mL | NDC 70860-600-02 50 mg per 10 mL | NDC 70860-601-10 ATHENEX AccuraSEETM PACKAGING AND LABELING BIG, BOLD AND BRIGHT — TO HELP YOU SEE IT, SAY IT AND PICK IT RIGHT DIFFERENTIATION IN EVERY LABEL, DESIGNED TO HELP REDUCE MEDICATION ERRORS PLEASE SEE FULL PRESCRIBING INFORMATION, INCLUDING BOXED WARNING, FOR MIDAZOLAM INJECTION, USP, ENCLOSED. THE NEXT GENERATION OF PHARMACY INNOVATION To order, call 1-855-273-0154 or visit www.Athenexpharma.com Midazolam Injection, USP 2 5 mg NDC 70860-600-02 0 NDC 70860-601-10 2 mg per 2 mL mg 50 mg per 10 mL DESCRIPTION Glass Vial DESCRIPTION Glass Vial CONCENTRATION 1 mg per mL CONCENTRATION 5 mg per mL CLOSURE 13 mm CLOSURE 20 mm UNIT OF SALE 25 vials UNIT OF SALE 10 vials BAR CODED Yes BAR CODED Yes STORAGE Room Temp. STORAGE Room Temp. • AP RATED • PRESERVATIVE-FREE • AP RATED • NOT MADE WITH NATURAL RUBBER LATEX • NOT MADE WITH NATURAL RUBBER LATEX CHOOSE AccuraSEETM FOR YOUR PHARMACY Our proprietary, differentiated and highly-visible label designs can assist pharmacists in accurate medication selection. With a unique label design for every Athenex product, we’re offering your pharmacy added AccuraSEE. The idea is simple: “So what you see is exactly what you get.” Athenex, AccuraSEE and all label designs are copyright of Athenex. ©2020 Athenex. 000527 To order, call 1-855-273-0154 or visit www.Athenexpharma.com • Midazolam hydrochloride mufti-dose vial, is not intended for intrathecal or epidural • Anesthetic and sedation drugs are a necessary part of the care of children needing Midazolam Injection, USP administration, and is contraindicated for use in premature infants, because the formulation surgery, other procedures, or tests that cannot be delayed, and no specific medications INDICATIONS AND USAGE contains benzyl alcohol as a preservative. -
Why Maryland's Capital Punishment Procedure Constitutes Cruel and Unusual Punishment Matthew E
University of Baltimore Law Review Volume 37 Article 6 Issue 1 Fall 2007 2007 Comments: The rC ime, the Case, the Killer Cocktail: Why Maryland's Capital Punishment Procedure Constitutes Cruel and Unusual Punishment Matthew E. Feinberg University of Baltimore School of Law Follow this and additional works at: http://scholarworks.law.ubalt.edu/ublr Part of the Law Commons Recommended Citation Feinberg, Matthew E. (2007) "Comments: The rC ime, the Case, the Killer Cocktail: Why Maryland's Capital Punishment Procedure Constitutes Cruel and Unusual Punishment," University of Baltimore Law Review: Vol. 37: Iss. 1, Article 6. Available at: http://scholarworks.law.ubalt.edu/ublr/vol37/iss1/6 This Article is brought to you for free and open access by ScholarWorks@University of Baltimore School of Law. It has been accepted for inclusion in University of Baltimore Law Review by an authorized administrator of ScholarWorks@University of Baltimore School of Law. For more information, please contact [email protected]. THE CRIME, THE CASE, THE KILLER COCKTAIL: WHY MARYLAND'S CAPITAL PUNISHMENT PROCEDURE CONSTITUTES CRUEL AND UNUSUAL PUNISHMENT I. INTRODUCTION "[D]eath is different ...." I It is this principle that establishes the death penalty as one of the most controversial topics in legal history, even when implemented only for the most heinous criminal acts. 2 In fact, "[n]o aspect of modern penal law is subjected to more efforts to influence public attitudes or to more intense litigation than the death penalty.,,3 Over its long history, capital punishment has changed in many ways as a result of this litigation and continues to spark controversy at the very mention of its existence. -
The Last Days of Night
FEATURE CLE: THE LAST DAYS OF NIGHT CLE Credit: 1.0 Thursday, June 14, 2018 1:25 p.m. - 2:25 p.m. Heritage East and Center Lexington Convention Center Lexington, Kentucky A NOTE CONCERNING THE PROGRAM MATERIALS The materials included in this Kentucky Bar Association Continuing Legal Education handbook are intended to provide current and accurate information about the subject matter covered. No representation or warranty is made concerning the application of the legal or other principles discussed by the instructors to any specific fact situation, nor is any prediction made concerning how any particular judge or jury will interpret or apply such principles. The proper interpretation or application of the principles discussed is a matter for the considered judgment of the individual legal practitioner. The faculty and staff of this Kentucky Bar Association CLE program disclaim liability therefore. Attorneys using these materials, or information otherwise conveyed during the program, in dealing with a specific legal matter have a duty to research original and current sources of authority. Printed by: Evolution Creative Solutions 7107 Shona Drive Cincinnati, Ohio 45237 Kentucky Bar Association TABLE OF CONTENTS The Presenter .................................................................................................................. i The War of the Currents: Examining the History Behind The Last Days of Night .................................................................................................... 1 AC/DC: The Two Currents